What's It Like to Work at Resilience (resilience.com).?

Key Insight for Candidates

• Mission & Purpose: Mission-driven work is centered on enabling partners to manufacture complex medicines, including advanced biologics, cell and gene therapy, and aseptic drug product under GMP standards. The technical scope and patient-facing impact are positioned as meaningful and challenging across scientific and manufacturing roles.
• Innovation & Products: Modern platforms and modalities (e.g., viral vectors, mRNA, advanced biologics, sterile fill/finish) are part of the company’s stated focus, offering exposure to cutting-edge manufacturing problems. Publicized partnerships and investments in select hubs suggest opportunities to work on high-throughput, commercial-leaning programs.
• Benefits & Perks: A comprehensive benefits package is repeatedly highlighted, including health coverage, savings programs, well-being resources, and other supports that are described as competitive for biopharma employers. Compensation and benefits are also characterized as a relative strength, though experiences are portrayed as role- and location-dependent.

• Job Insecurity: Significant restructuring, layoffs, and the announced wind-down of multiple facilities (including six facilities in 2025) create tangible uncertainty about site-level continuity. The guidance repeatedly emphasizes that stability depends heavily on the specific facility, business line, and near-term book of work.
• Change Fatigue: Ongoing portfolio reshaping, leadership turnover, and shifting priorities are described as common, with day-to-day experience varying widely by site and function. The repeated need for diligence on 12–24 month outlook implies a persistently fluid operating environment that can be difficult for those seeking predictability.
• Workload & Burnout: The CDMO model and GMP environment are described as schedule-intense, audit-heavy, and documentation-driven, with frequent off-hours or shift expectations in manufacturing and quality roles. Client-driven timelines and tech-transfer milestones can compress workloads and strain work–life balance, especially during critical campaigns.